Novo Nordisk Presents: Fill & Download for Free

What do you see here?Ugly ass lamp? I don't see a lamp. I see a hood, I see the material, I see no cords, so perhaps that is getting less popular? I'd be curious to see what lightbulb they use.. My perception is different.In other words, I don't have an investing strategy. Strategy means planning, planning means stress, I don't do stress.I don't look for opportunities. I get presented opportunities, sometimes a few times a day sometimes once a week.I hear Tusk talk on the news, and I might get an idea about how to deal with the GBP/EUR fluctuations and will test it out.I see polls on the British elections, and (with the inconsistency of polls of last referendum where they expected remain yet it became Brexit), and think, can i write an algorithm to capture the emotional volatility through a key word algorithm picking up comments from the daily mail, or twitter. And start with that..I see a fatty walking on the street, and i think, how are insulin producers doing? Let's investigate. Novo Nordisk?I'm flying Lufthansa and my flight is cancelled and I spontaneous go look at Lufthansa and its direct competitors and can be infatuated for the next three hours to see if it is a good investment.Or for example right now, I'm in the train to BerlinSo who produces trains, how are these firms doing? Which leads me into Bombardier, Alstom etc.

Denmark.We have a lot of great entrepreneurs and business leaders due to fact that Denmark is one of the best countries for business (source: Forbes: Denmark World's Best Country for Business). We have great conditions such as flexible labour market, high productivity, and no constraints in terms of overtime. Furthermore, I believe our key to successful entrepreneurship has been the the freedom to follow your dreams while having the economic security. We do not jeopardize our future by making one bad economic judgment. If we fail, we will always have the economic and moral support from our country.I am truly proud that we, as such a small country, can present great world-wide brands as LEGO, Maersk, Vestas Wind Systems, Novo Nordisk, Skype (co-founded with a Swedish guy), Arla, Carlsberg, Danish Crown, and I could go on.

All doctors involved in diabetes care want a stable really long acting insulin - so not the by now obsolete (but cheap) NPH insulin of the past, but the newer insulin analogues, Insulin Detemir, Insulin Glargine or the newest and most stable insulin Degludec - that doesn't cause nightly low blood sugars, is stable and has reproducible effects on one's blood sugar in the same patient, and ideally also between patients, keeping the blood sugar levels before meals low without being hypoglycemic when not having eaten for a longer time e.g. nights.This is another study comparing the effects of Insulin Glargine and Insulin Degludec, at present the most stable and longacting insulin availableDegludec also has the least intraindividual variability:U300 Glargine is available though, thanks anon for reminding me, although I couldn't find a head to head comparison between the effects of Insuline Degludec and U300 Glargine is seems more stable than U100 Glargine seeThis overview would be useful to anyone interested:The post-meal blood sugar control is left to the body's own residual insulin production, aided by oral meds e.g. metformin, maybe sulfonylurea derivatives, even injectable Glucagon-like peptide-1 agonist, but that is more for an internist or endocrinologist/diabetologist to prescribe.The effect would be something like this (in this example we inject rapid acting insulin analogues when having a meal as often as one has a meal)At present Novo Nordisk in the US has refiled for FDA approval for their newest long acting insulin analogue Degludec (Tresiba®), in Europe it already is available. So for the US Insulin Glargine seems to be the best available long acting insulin analogue.